Alpha 2.0
Login Register
» Articles » PMID: 23349214

Tiotropium Bromide Triple Combination Therapy Improves Lung Function and Decreases Asthma Exacerbations

Overview
Journal Evid Based Med
Publisher BMJ Publishing Group
Specialties General Medicine
Public Health
Date 2013 Jan 26
PMID 23349214
Citations 3
Authors
Stephen P Peters
Affiliations
Soon will be listed here.
Citing Articles

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Ishiura Y, Fujimura M, Ohkura N, Hara J, Kasahara K, Ishii N Int J Chron Obstruct Pulmon Dis. 2020; 15:269-277.

PMID: 32103926 PMC: 7014958. DOI: 10.2147/COPD.S231004.

Effect of triple therapy in patients with asthma-COPD overlap
.

Ishiura Y, Fujimura M, Ohkura N, Hara J, Kasahara K, Ishii N Int J Clin Pharmacol Ther. 2019; 57(8):384-392.

PMID: 31232275 PMC: 6637394. DOI: 10.5414/CP203382.

Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease.

Zhao D, Ling C, Guo Q, Jin J, Xu H Exp Ther Med. 2018; 16(6):4578-4584.

PMID: 30542407 PMC: 6257237. DOI: 10.3892/etm.2018.6773.